AzTrials
AzTrials

Childhood ObesitymHealthNCT06247202

Effect of Smart Phone Health Education on Overweight and Obese Schoolchildren's Dietary Habits and Body Composition

A study testing Smart Phone Education (mhealth) and Paper Education (conventional) in people with Childhood Obesity, run by Universiti Sains Malaysia at 1 site in United Arab Emirates.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study is to investigate the effect of mobile health nutrition education intervention in the changing of dietary habits and body composition of overweight and obese 8-12 years old children in Sharjah, United Arab Emirates and to compare its effectiveness to paper educational intervention among the same… Read more about this study

Who is it for?
Ages 8 to 12 years
Conditions the study is for
Childhood Obesity
What is being tested?
Smart Phone Education (mhealth) and Paper Education (conventional)
Could I receive a placebo?
No, everyone receives an active treatment
How many people
146 participants
Where
1 siteUnited Arab Emirates
Study dates
1 Dec 2023to 10 May 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 8 to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • Overweight/obese children (over 2 SD based on the WHO Growth Reference (2007)).
  • Between 8 - 12 years old.
  • Attending school in Sharjah, UAE.

Who cannot join

  • Children on a specific diet.
  • Children who have any chronic diseases.
  • Parents qualify if their children meet the inclusion criteria, they can read and speak in Arabic, they plan to stay in Sharjah for six months from the beginning of the intervention, and they own and use a smart phone.

Trial locations and contacts

1 site in 1 country.

United Arab Emirates1 site
  • University of Sharjah

    Sharjah city

Other trials in United Arab Emirates

About this study

Official title: Effect of Smart Phone Delivered Health Education Intervention on Overweight and Obese Schoolchildren's Dietary Habits and Body Composition in the UAE

The aim of this study is to investigate the effect of mobile health nutrition education intervention in the changing of dietary habits and body composition of overweight and obese 8-12 years old children in Sharjah, United Arab Emirates and to compare its effectiveness to paper educational intervention among the same age group.

The main questions it aims to answer are:

Read more
  1. Are there any significant changes in dietary habits, physical activity and body composition among overweight and obese school-age children after three months of mobile health intervention?
  2. Is there any significant difference between the effect of smart phone delivered and paper delivered interventions (changes in dietary habits, physical activity and body composition) among overweight and obese school-age children after three months of interventions?
  3. Are there any significant changes in the obesity inflammatory panel among overweight and obese school-age children after three months of mobile health intervention?
  4. Is there any significant difference in the sustainability of the outcomes between mobile health and paper delivered interventions among overweight and obese school-age children two months after the end of the intervention?
  5. Are there any significant changes in nutrition related knowledge among parents of overweight and obese school-age children after three months of intervention?

Participants (children with their parents) will be randomly divided into intervention group and control group. Parents of children from the intervention group will receive two text messages/graphics per week about healthy eating and physical activity (PA) on their mobile phones during the intervention period (3 months). While parents in the control group will receive a one-time printed handout containing the same messages at the beginning of the intervention period.

Assessment of children's anthropometry, dietary intake and physical activity will be evaluated pre and post intervention and one more time after a two months period of maintenance after the end of the intervention. Parents' nutrition knowledge will be evaluated pre and post intervention only. Also, children salivary obesity markers will be measured at baseline and at the end of the intervention period to explore the effects of the intervention on inflammatory markers associated with obesity.

Being tested
Smart Phone Education (mhealth), Paper Education (conventional)
Medical subject headings
Pediatric Obesity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Smart Phone Education (mhealth)Other

    Nutrition and Health Education module delivered through m-health approach (smart phones)

  • Paper Education (conventional)Other

    Nutrition and Health Education module delivered through conventional approach (paper)

Study groups in NCT06247202
Study groupRoleWhat they receive
Intervention groupExperimentalParticipants in the intervention group will receive smart phone delivered health education in the form of text messages through WhatsApp.
Receives: Other: Smart Phone Education (mhealth)
Control groupActive comparatorParticipants in the control group will receive paper delivered health education in the form of a one time handout.
Receives: Other: Paper Education (conventional)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Weight

    Will be measured using a Body Composition Analyzer, and will be measured in Kilograms

    Measured: 3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

  2. Height

    Will be measured using a standing Stadiometer, and will be measured in Centimetres

    Measured: 3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

  3. Body Mass Index

    Will be calculated using the weight and height, and will be measured in kg/m^2

    Measured: 3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

  4. Body Fat Mass

    Will be measured using a Body Composition Analyzer, and will be measured in Kilograms

    Measured: 3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

  5. Fat Free Mass

    Will be measured using a Body Composition Analyzer, and will be measured in Kilograms

    Measured: 3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

  6. Total Body Water

    Will be measured using a Body Composition Analyzer, and will be measured in Kilograms

    Measured: 3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

  7. Parents' Knowledge

    Using a valid Nutrition Knowledge Attitude Practice Questionnaire - no scale

    Measured: twice: before intervention (at 0 months) and after intervention (at 3 months).

  8. Children's Dietary Intake

    Using 24 Hours' Diet recall (3 days).

    Measured: 3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

  9. Children's Physical Activity

    Using a valid Physical Activity Questionnaire - no scale

    Measured: 3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)

  10. Salivary C-Reactive Protein Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    Measured: twice: before intervention (at 0 months) and after intervention (at 3 months).

  11. Salivary Adiponectin (Acrp30) Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    Measured: twice: before intervention (at 0 months) and after intervention (at 3 months).

  12. Salivary Monocyte Chemoattractant Protein-1 (MCP-1/CCL2) Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    Measured: twice: before intervention (at 0 months) and after intervention (at 3 months).

  13. Salivary Complement Factor D (Adipsin) Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    Measured: twice: before intervention (at 0 months) and after intervention (at 3 months).

  14. Salivary Interleukin 6 (IL-6) Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    Measured: twice: before intervention (at 0 months) and after intervention (at 3 months).

  15. Salivary Interleukin 10 (IL-10) Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    Measured: twice: before intervention (at 0 months) and after intervention (at 3 months).

  16. Salivary Leptin (OB) Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    Measured: twice: before intervention (at 0 months) and after intervention (at 3 months).

  17. Salivary Resistin Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    Measured: twice: before intervention (at 0 months) and after intervention (at 3 months).

  18. Salivary Plasminogen Activator Inhibitor-1 (Serpin E1 / PAI-1) Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    Measured: twice: before intervention (at 0 months) and after intervention (at 3 months).

  19. Salivary Tumour Necrosis Factor alpha (TNF alpha) Concentration

    Concentration in saliva samples will be assessed using Luminex Performance Human Obesity Panel (10-Plex)

    Measured: twice: before intervention (at 0 months) and after intervention (at 3 months).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Feb 2024
  2. Study start1 Dec 2023
  3. Primary completion10 Mar 2024
  4. Study completion10 May 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
Participants will be randomly divided into intervention group and control group. intervention group will receive smart phone delivered nutrition education while control group will receive paper delivered nutrition education.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
146 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06247202
Sponsor's protocol ID
USM/JEPeM/KK/23020205
Other IDs
REC-22-09-05-01
Acronym
mHealth
Status last verified
May 2024
First submitted
7 Jan 2024
Last updated
14 May 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Smart Phone Education (mhealth) and Paper Education (conventional) in people with Childhood Obesity, run by Universiti Sains Malaysia at 1 site in United Arab Emirates.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United Arab Emirates. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Weight (time frame: 3 times: before intervention (at 0 months), after intervention (at 3 months), after maintenance (at 5 months)). The study lists 19 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in